On April 17, 2020, the U.S. Court of Appeals for the Federal Circuit (CAFC) reversed the U.S. District Court for the District of Massachusetts’ ruling in the matter of CardioNet, LLC v. InfoBionic, Inc., finding that CardioNet’s patent claims detail specific methods to improve cardiac monitoring technology rather than merely invoking “generic processes and machinery.”
The patent infringement dispute began in March 2017, when CardioNet alleged that its competitor InfoBionic infringed a patent related to enhanced heartbeat variability detection.
Read more at the National Law Review
Read a related article: CardioNet, LLC Et Al v. InfoBionic, Inc. Dismissed After Findings of Patent Ineligibility
